Arbutus to repurchase up to $230M of shares in tender offer WARMINSTER, Pa., Aug. Key points and original sources are listed below.

• Arbutus to repurchase up to $230M of shares in tender offerS1

• WARMINSTER, Pa., Aug. 21, 2026 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced plans to commence a modified “Dutch Auction”...S2